With Timothy Blanchard, Bernadette Broccolo, Allen Kim, Joan Polacheck
Providers and research sponsors must consider two recent Medicare-related administrative issuances indicating CMS and OIG interpretations regarding provisions of clinical trial arrangements and Medicare payment for routine cost services in clinical trials.